Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Trostberg, January 14, 2021 – After an extremely positive business performance at the end of the year, AlzChem Group AG will close fiscal year 2020 with sales slightly above and adjusted EBITDA significantly above the most recent forecast.
The company now expects to generate slightly higher consolidated sales of approximately EUR 379 million in fiscal year 2020 compared to the previous year (2019: EUR 376.1 million; last forecast: stable to slightly declining). Adjusted EBITDA will increase significantly to at least EUR 53 million (2019: EUR 50.1 million; last forecast: stable to moderately declining).
The reasons for the very positive development are the recovery of the overall markets, in particular the strong increase in demand from the pharmaceutical industry and the automotive sector.
The above figures are preliminary. The final results for fiscal year 2020 will be announced on March 19, 2021.
Tags:
About Alzchem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global megatrends of sustainability, population growth and healthy aging. AlzChem products offer attractive solutions in a wide range of applications.
The company sees interesting growth prospects for itself above all in the fields of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The broad product range includes, for example, dietary supplements, plant growth regulators and precursors for corona tests.
The company employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
Contact
Sabine Sieber
Head of Investor Relations & Communications
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany